Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Provention Bio Inc. (PRVB)

12.9   0.43 (3.45%) 02-26 16:00
Open: 12.43 Pre. Close: 12.47
High: 13.34 Low: 12.13
Volume: 679,642 Market Cap: 615M
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-6527, an oral CSF-1R inhibitor, which is in Phase IIa clinical trial for the treatment of Crohn's disease; PRV-300, an anti-TLR3 mAb, which is in Phase Ib clinical trial for the treatment of ulcerative colitis; PRV-3279, which is in phase Ib/IIa for the treatment of lupus; PRV-101, a multivalent coxsackie virus vaccine for the prevention of acute Coxsackie Virus B Vaccine and the prevention of the onset of T1D; and PRV-015, which is in phase IIb for the treatment of gluten-free diet non-responding celiac disease. The company has a licensing and co-development agreement with Amgen Inc. for PRV-015, a novel anti-IL-1

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 13.346 - 13.427 13.427 - 13.504
Low: 11.953 - 12.041 12.041 - 12.126
Close: 12.758 - 12.894 12.894 - 13.025

Technical analysis

as of: 2020-02-26 4:31:39 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 18.77     One year: 21.61
Support: Support1: 12.13    Support2: 10.09
Resistance: Resistance1: 16.07    Resistance2: 18.50
Pivot: 14.73
Moving Average: MA(5): 13.77     MA(20): 14.91
MA(100): 11.40     MA(250): 8.78
MACD: MACD(12,26): -0.39     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 8.39     %D(3): 18.75
RSI: RSI(14): 34.60
52-week: High: 22.82  Low: 2.20  Change(%): 405.9
Average Vol(K): 3-Month: 67803  10-Days: 49370

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
PRVB has closed above bottom band by 3.6%. Bollinger Bands are 25.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Provention Bio to Present at Upcoming Conferences
OLDWICK, N.J., Feb. 19, 2020 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical-stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that management will present at two upcoming conferences: The 9th Annual SVB…

Provention Bio Appoints Jason Hoitt as Chief Commercial Officer
/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated…

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 47.64
Shares Float (M) 30.67
% Held by Insiders 28.00
% Held by Institutions 19.84
Shares Short (K) 1970
Shares Short P. Month (K)

Stock Financials

EPS -1.010
Book Value (p.s.) 1.920
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -30.5
Return on Equity (ttm) -49.1
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -32.10
Levered Free Cash Flow (M) -18.48

Stock Valuations

P/E -12.77
P/E Growth Ratio 0.03
P/BV 6.72
P/CF -19.15

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.